GeneDx Holdings Corp - Ordinary Shares - Class A
WGS
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.95B
Close$
$-140.29
324.7% downside
Current Fair Value
324.7% downsideOvervalued by 324.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.95 Billion |
|---|---|
| Enterprise Value | $2.02 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.73 |
| Beta | 1.91 |
| Outstanding Shares | 29,335,126 |
Return
| Return on Equity | -30.62% |
|---|---|
| Return on Assets | -15.37% |
| Return on Invested Capital | -9.87% |
Valuation & Multiples
| P/E Ratio | -24.68 |
|---|---|
| PEG | -2.84 |
| Price to Sales | 4.16 |
| Price to Book Ratio | 7.8 |
| Enterprise Value to Revenue | 4.57 |
| Enterprise Value to EBIT | -48.96 |
| Enterprise Value to Net Income | -26 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.66 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 13, 2026
EPS Estimate
$-0.01
Average shareholder expectationRevenue Estimate
$112.95 M
Average shareholder expectationNext Earnings Call
Expected Date
August 4, 2026
EPS Estimate
$-0.19
Average shareholder expectationRevenue Estimate
$111.01 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 47.14% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.06%▼ 115.16% |
|---|---|
| Total Invested | $21.30M▼ 98.94% |
| Investors Holding | 5▼ 248.00% |
ESG Score
No data
About GeneDx Holdings Corp
3 employeesSema4 is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. Sema4 is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and g...